Find activities

111 results

  • MSAC Consultation Survey - Application 1818

    MSAC Application 1818 – Expansion of specialist supervision criteria for MBS and PBS items for integrated, closed-system, extracorporeal photopheresis and methoxsalen (UVADEX®) for the treatment of Cutaneous T-Cell Lymphoma and chronic Graft Versus Host Disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Closed 12 June 2026

  • MSAC Consultation Survey - Application 1785 - resubmission

    A further period of consultation is open on application 1785 – Dexcom ONE+ Continuous Glucose Monitoring (CGM) System for people with insulin-dependent type 2 diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. MSAC previously considered application... More
    Closed 12 June 2026

  • EOI for feedback on consumer input

    The Office of Health Technology Assessment’s (OHTA) Consumer Evidence and Engagement Unit (CEEU) is exploring practical ways to provide consumers and consumer organisations with clear and consistent feedback about how their input is used in health technology assessment (HTA) processes and in HTA committee discussions. As part of this work, we are conducting an online survey and having virtual conversations with consumer organisations that will focus on: ... More
    Closed 26 June 2026

  • MSAC Consultation Survey - Application 1823

    MSAC application 1823 177 Lutetium PSMA-617 for prostate specific membrane antigen (PSMA)-positive, taxane-naïve patients with metastatic castrate resistant prostate cancer (mCRPC). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1822

    MSAC application 1822 F-18 Fluorodeoxyglucose (FDG) positron emission tomography (PET) for evaluation of complex infection. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1825

    MSAC application 1825 Transcranial Doppler bubble test for patent foramen ovale. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1821

    MSAC application 1821 Testing for Chromogranin A in patients with neuroendocrine neoplasms. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1826

    MSAC application 1826 N-Terminal-pro Brain Natriuretic Peptide (NT-proBNP) testing to support management of patients with heart failure. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1820

    MSAC application 1820 In situ hybridisation (ISH) testing of tumour tissue to detect viral genomes (EBV and HPV). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1738.1

    MSAC application 1738.1 Investigations to support the use of PBS subsidised lecanemab in people with mild cognitive impairment and mild dementia due to Alzheimer’s disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... More
    Closed 10 July 2026

  • MSAC Consultation Survey - Application 1827

    MSAC application 1827 Testing for hepatitis B virus (HBV) and hepatitis B virus surface antigen (HBsAg) to support the use of PBS subsidised bepirovirsen in people with chronic hepatitis B (CHB). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Closed 10 July 2026

  • Feedback on consumer input

    We are seeking your views on how consumers and consumer organisations should receive feedback after they provide input on HTA committee agenda items. The Office of Health Technology Assessment’s (OHTA) Consumer Evidence and Engagement Unit (CEEU) is exploring practical ways to give clear and consistent feedback to consumers and consumer organisations about how their input was used during the health technology assessment (HTA) process and in HTA committee... More
    Closed 13 July 2026

  • Public consultation on items to be considered by the PBAC (November 2026)

    Consultation has opened for the November 2026 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines and vaccines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. Information provided by consumers helps the committee... More
    Closes 16 September 2026

  • 1754 - Surgical Procedures for Gender Affirmation in Adults with Gender Incongruence - resubmission

    A further period of consultation is open on application 1754 – Surgical Procedures for Gender Affirmation in Adults with Gender Incongruence, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. Background MSAC application 1754 is progressing via a... More
    Closes 9 October 2026

  • MSAC Consultation Survey - Application 1819

    MSAC application 1819 Breyanzi (lisocabtagene maraleucel) for the treatment of large B-cell lymphoma. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closes 9 October 2026

  • MSAC Consultation Survey - Application 1803

    MSAC application 1803 - Implantation of an active middle ear implant (Vibroplasty) for treatment of mixed and conductive hearing loss. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Closes 9 October 2026

  • MSAC Consultation Survey - Application 1802

    MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closes 9 October 2026

  • MSAC Consultation Survey - Application 1810

    MSAC application 1810 Genomic testing for the diagnosis of primary immunodeficiency (PID). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does... More
    Closes 9 October 2026

  • CEEU/HTA Updates

    Receive regular HTA Engage e-newsletters for updates on HTA activities and announcements from the CEEU, including open consultation dates for PBAC and MSAC meeting agenda items. More
    Closes 1 June 2028

  • MSAC Updates

    Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates. More
    Closes 1 June 2028

  • PBAC Updates

    Subscribe to PBS.gov.au email notification of the Pharmaceutical Benefits Scheme (PBS) news, including PBAC meeting agendas, consultations and outcomes. More
    Closes 1 June 2028
111 results. Page 4 of 4